8329213

2 known cases. View patent page →

Cases
2
Active
1
1 closed
Filed
2024
Top venue
D. New Jersey
1 case

Ipsen Biopharmaceuticals, Inc. et al. v. Conjupro Biotherapeutics, Inc. et al.

pending; discovery
Docket:
1:24-cv-04991
Filed:
2024-04-15

Lead consolidated patent infringement action concerning an ANDA/505(b)(2) NDA No. 218923 for generic Onivyde. The complaint affirmatively asserts multiple patents, and US 10,993,914 is in the case through Conjupro/CSPC's declaratory-judgment counterclaims based on a Paragraph IV certification.

Untitled case

unknown
Docket:
3:24-cv-04991
Patents:8329213

Documented litigation flag for US 8,329,213 in the District of New Jersey, case No. 3:24-cv-04991, per Unified Patents litigation data linked from Google Patents. The caption, parties, filing date, and outcome were not verified in the narrative.